Altor BioScience

Altor BioScience Corporation is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapy drugs for the treatment of cancer, viral infections, and autoimmune diseases. It provides STAR Fusion reagents for the diagnosis and targeting of cancer and viral infections, and STAR Multimer reagents for research and design of anticancer and antiviral vaccines. The company's clinical products include a monoclonal antibody for the prevention and treatment of staphylococcal infections in premature infants, and STAR-Ck or ALT-801, an anticancer drug. It also has products at various stages of development, such as fusion agents for cancer and viral infections, immunotherapeutic agents targeting staphylococcal infections, gene therapies for cancer, and multimeric reagents. Additionally, the company offers products for detecting new disease targets. Its products are used for the direct and quantitative detection of endogenous peptide antigens expressed in diseased cells and tissues. The company was founded in 2002 and is headquartered in Miramar, Florida.